pi3k/akt pathway inhibition for the treatment of metastatic castrate-resistant prostate cancer
Published 3 years ago • 846 plays • Length 1:00:07Download video MP4
Download video MP3
Similar videos
-
1:00:07
pi3k/akt pathway inhibition for metastatic castrate-resistant prostate cancer
-
3:18
pi3k/akt pathway aberrations in mcrpc
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer
-
22:55
update on mechanisms of resistance in castration-resistant prostate cancer
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
1:53:11
what's new in the management of hormone naïve & castrate resistant prostate cancer webcast (2021)
-
0:52
dr. lawrence karsh on treatment sequencing in metastatic castration-resistant prostate cancer
-
5:05
castrate resistant, non-metastatic prostate cancer (m0 state) | prostate cancer staging guide
-
1:53
abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
-
5:42
atezolizumab with radium-223 in metastatic castrate-resistant prostate cancer
-
5:46
metastatic castration-resistant prostate cancer – new learnings and perspectives
-
38:49
the pi3k / akt / mtor pathway and cancer part 1
-
26:17
immunotherapy for castrate-resistant prostate cancer
-
13:04
urogripp: how to manage castrate resistant metastatic prostate cancer? - dr. jayshree
-
37:46
systemic therapies for mhspc and castrate resistant prostate cancer
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
3:56
about metastatic castrate-resistant prostate cancer
-
33:19
castration resistant prostate cancer - developments and challenges from 2020
-
24:37
the role of therapeutic layering in optimizing treatment for patients with prostate cancer